Purpose. To evaluate COVID-associated lesions of the posterior segment of the eye and analyze them in terms of severity. Material and methods. The study was carried out at the Republican Clinical Ophthalmological Hospital of the Ministry of Healthcare of Chuvashia, Cheboksary. For the period from May 2020 to April 2021, 58 complaints were registered from patients with a sharp deterioration in vision against the background of a confirmed coronavirus infection. All patients underwent a standard ophthalmologic examination. After the examination and verification of the diagnosis, the patients were divided into two groups. The first group: COVID - associated vascular diseases of the posterior segment of the eye, and the second group - COVID - associated inflammatory diseases of the posterior segment of the eye. Results. In the first group, when macular edema was detected using OCT, intravitreal instillation of ranibizumab (the average number of injections was 3) followed by paravasal laser coagulation of the retina. In the second group, patients received pathogenetic therapy - glucocorticosteroids, non-steroidal anti-inflammatory, desensitizing drugs both locally and systemically, cycloplegia. We noted that COVID-associated inflammatory diseases of the posterior eye segment are distinguished by the severity of the course, a tendency to relapse and, often, an unfavorable outcome. Conclusions. Coronavirus infection tends to affect the posterior segment of the eye. COVID-associated diseases of the posterior segment of the eye are distinguished by the severity of the course, a tendency to relapse and, often, an unfavorable outcome. In young patients, inflammatory manifestations of coronavirus infection in the posterior segment of the eye predominate. It can be assumed that coronavirus infection is neurotropic according to the frequent involvement of the optic nerve in the pathological process. Key words: coronavirus infection, posterior segment of the eye, COVID-associated vascular diseases of the posterior segment of the eye, COVID-associated inflammatory diseases of the posterior segment, neurotropicity.